Committed to Medical Innovations
Every day—in research labs across eastern Massachusetts—investigators, doctors and nurses at Partners HealthCare are working to discover new treatment options, medical devices and technology to improve the lives and outcomes of patients. Partners HealthCare Innovation works directly with researchers at Brigham and Women’s Hospital, Massachusetts General Hospital, McLean Hospital and Spaulding Hospital to commercialize their innovations. It is our mission to enable commercialization through the best route for a given technology, and ensure that technologies can benefit patients.
BOSTON–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Syntimmune today announced that they have entered into a definitive agreement for Alexion to acquire Syntimmune, a clinical-stage biotechnology company developing antibody therapeutics targeting the neonatal Fc receptor (FcRn). SYNT001 – a humanized monoclonal antibody that inhibits the interaction of FcRn with Immunoglobulin G (IgG) and IgG immune complexes –…Read More
We are pleased to alert you to the call for proposals for Pfizer’s Centers for Therapeutic Innovation (CTI) program for collaborative development of novel biotherapeutics. CTI supports translational programs in oncology, autoimmunity & inflammation, metabolic and rare diseases. Deadline to submit to Innovation: Friday, November 2nd 2018 How to apply: Please use the CTI Template to complete a non-confidential pre-proposal (max…Read More
The 2018 World Medical Innovation Forum focused on the advancements and opportunities of Artificial Intelligence. The event brought together industry-leading CEOs, Partners' HIT experts, investors and deal makers to share perspectives on how cognitive computation, machine learning, and big date are having a transformative impact on patient care.
Career Development Opportunities for Future Leaders in Translational Medicine
The Innovation Fellows Program enables personnel exchanges between Partners hospitals and participating industry. Biopharmaceutical, device, venture capital, digital health, payors, and consulting firms engage with early career Harvard faculty and trainees appointed at Brigham and Women’s Hospital, Massachusetts General Hospital and McLean Hospital. Fellows gain the competencies they need to become future leaders in health care through experiential opportunities.